U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 202106

Expand all

MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER (MEROPENEM)
500MG/VIAL
Marketing Status: Prescription
Active Ingredient: MEROPENEM
Proprietary Name: MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 500MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N202106
Product Number: 001
Approval Date: Apr 30, 2015
Applicant Holder Full Name: B BRAUN MEDICAL INC
Marketing Status:  Prescription
Patent and Exclusivity Information
MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER (MEROPENEM)
1GM/VIAL
Marketing Status: Prescription
Active Ingredient: MEROPENEM
Proprietary Name: MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 1GM/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N202106
Product Number: 002
Approval Date: Apr 30, 2015
Applicant Holder Full Name: B BRAUN MEDICAL INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top